Sections
<
You are here: Posterior Cortical Atrophy
Clinical evaluation
Dr. Dickerson performs clinical evaluations aimed at diagnosis and treatment as a major focus of his clinical work with the MGH Memory Disorders Unit and Alzheimer's Disease Research Center, and also as director of the MGH FTD Unit. Many individuals who initially come in for an evaluation get involved in research. Feel free to contact Dr. Dickerson via email (bdickerson@partners.org) to discuss a clinical evaluation. Read more here on clinical evaluation of cognitive impairment.
 

Welcome: Posterior Cortical Atrophy Program

Document Actions

Posterior Cortical Atrophy (PCA) is a form of gradually progressive brain disorder related to neurodegeneration in the back parts of the brain, usually involving the parietal lobes.


Information regarding posterior cortical atrophy (PCA) clinical research program

The major goals of this clinical research program are to improve our understanding of the changes in the brain and behavior that characterize posterior cortical atrophy (PCA), with the goal of improving our ability to diagnose, monitor, and treat the symptoms of this syndrome. In addition, we aim to connect patients and families with additional resources for assessment and treatment, planning, and education.

The clinical research portion of the program involves a high-resolution MRI scan and additional visual, memory, language, and executive and attentional testing. In addition, interviews are performed with a spouse, sibling, child, or other family member or friend to obtain information about symptoms in daily life and in order to obtain additional information about the impact of PCA on family members. These evaluations are performed every six months, with repeat brain scans every year.

In addition, records obtained as part of previous clinical evaluations are reviewed. Participants are also offered the opportunity to participate in the Massachusetts Alzheimer’s Disease Research Center Longitudinal Cohort and related studies, which involve blood sampling for genetic analysis and discussion of the possibility of planning for brain donation.

Besides the research program outlined above, we aim to connect PCA patients and families with additional resources as needed. A network of other specialists who assist with our PCA program, including neuro-opthalmology at Mass Eye and Ear Institute, occupational therapy, physical therapy, speech and language pathology, social work, neuropsychiatry, and genetic counseling. We also work closely with community resources, including psychotherapists, Boston metropolitan area support groups, driving evaluation centers, and others. For more information, please contact us at MGHFTDUnit@partners.org or call 617-726-5571 and ask for Mike Brickhouse.

The MGH PCA Clinical Research Program is a multidisciplinary program pursuing research and clinical care of patients with PCA. The program is an active ongoing collaboration between members of the departments of neurology, speech pathology, occupational therapy, radiology, social work, and psychiatry. If you are interested in participating, we are happy to discuss the program at any time.

Feel free to contact us for for information (MGHFTDUnit@partners.org).

Created by admin
Last modified 2009-1-19
Opportunities to participate
We are always happy to discuss our research with people who would like to participate, be they volunteers for scanning, donors, students, post-docs, or collaborators. See 'How to participate' above for more details.